TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Paralell Pharma Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
10,133
|
11,074
|
10,915 |
Financial expenses |
7
|
0 | |
Earnings before taxes |
3,003
|
843
|
3,700 |
Total assets |
10,341
|
12,313
|
13,900 |
Current assets |
1,375
|
1,925
|
2,137 |
Current liabilities |
312
|
388
|
536 |
Equity capital |
10,029
|
11,917
|
13,364 |
- share capital |
22
![]() |
22
![]() |
22 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
97.0%
|
96.8%
|
96.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
29.6%
|
7.6%
|
33.9% |
Return on assets (ROA) |
6.9%
|
26.6% | |
Current ratio |
440.7%
|
496.1%
|
398.7% |
Return on equity (ROE) |
29.9%
|
7.1%
|
27.7% |
Change turnover |
-900
|
134
|
1,705 |
Change turnover % |
-8%
|
1%
|
19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.